FY2020 EPS Estimates for UnitedHealth Group Inc (NYSE:UNH) Increased by Analyst
UnitedHealth Group Inc (NYSE:UNH) – Analysts at Jefferies Financial Group upped their FY2020 earnings estimates for shares of UnitedHealth Group in a report issued on Wednesday, October 14th. Jefferies Financial Group analyst D. Windley now expects that the healthcare conglomerate will post earnings per share of $16.71 for the year, up from their previous forecast of $16.47. Jefferies Financial Group has a “Hold” rating and a $335.00 price objective on the stock. Jefferies Financial Group also issued estimates for UnitedHealth Group’s Q1 2021 earnings at $4.65 EPS, Q2 2021 earnings at $4.35 EPS, Q3 2021 earnings at $4.87 EPS, Q4 2021 earnings at $4.76 EPS and FY2022 earnings at $21.06 EPS.
Several other equities analysts have also recently weighed in on the company. ValuEngine upgraded UnitedHealth Group from a “sell” rating to a “hold” rating in a report on Thursday, October 1st. UBS Group raised their price target on UnitedHealth Group from $319.00 to $330.00 and gave the company a “neutral” rating in a report on Friday. Stephens raised their price target on UnitedHealth Group from $325.00 to $335.00 and gave the company an “overweight” rating in a report on Thursday, July 16th. Bank of America raised their price target on UnitedHealth Group from $351.00 to $365.00 and gave the company a “buy” rating in a report on Friday, August 28th. Finally, Royal Bank of Canada raised their price target on UnitedHealth Group from $384.00 to $389.00 and gave the company an “outperform” rating in a report on Thursday. Four analysts have rated the stock with a hold rating, twenty-one have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $346.68.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.98 by $0.53. The company had revenue of $65.12 billion for the quarter, compared to the consensus estimate of $63.97 billion. UnitedHealth Group had a return on equity of 29.28% and a net margin of 6.90%. The firm’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the company earned $3.88 EPS.
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. raised its position in UnitedHealth Group by 7.5% during the 2nd quarter. Vanguard Group Inc. now owns 80,727,140 shares of the healthcare conglomerate’s stock valued at $23,810,470,000 after purchasing an additional 5,654,194 shares in the last quarter. State Street Corp raised its position in UnitedHealth Group by 0.5% during the 1st quarter. State Street Corp now owns 46,003,796 shares of the healthcare conglomerate’s stock valued at $11,472,427,000 after purchasing an additional 212,240 shares in the last quarter. Nuveen Asset Management LLC raised its position in UnitedHealth Group by 4.4% during the 2nd quarter. Nuveen Asset Management LLC now owns 7,294,171 shares of the healthcare conglomerate’s stock valued at $2,151,416,000 after purchasing an additional 305,797 shares in the last quarter. Sanders Capital LLC raised its position in UnitedHealth Group by 3.3% during the 2nd quarter. Sanders Capital LLC now owns 5,422,137 shares of the healthcare conglomerate’s stock valued at $1,787,646,000 after purchasing an additional 172,998 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in UnitedHealth Group by 0.8% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 4,794,237 shares of the healthcare conglomerate’s stock valued at $1,414,060,000 after purchasing an additional 39,532 shares in the last quarter. 86.39% of the stock is owned by institutional investors and hedge funds.
In related news, EVP Marianne D. Short sold 10,336 shares of the business’s stock in a transaction on Friday, August 28th. The stock was sold at an average price of $312.34, for a total transaction of $3,228,346.24. Also, EVP Marianne D. Short sold 12,000 shares of the business’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $321.34, for a total value of $3,856,080.00. Following the transaction, the executive vice president now owns 140,885 shares of the company’s stock, valued at approximately $45,271,985.90. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 47,336 shares of company stock valued at $14,928,276. 0.80% of the stock is owned by company insiders.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend was Friday, September 11th. UnitedHealth Group’s payout ratio is currently 33.09%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: Cost of Debt
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.